Vital Chemtech

Why is Vital Chemtech Ltd falling/rising?

As of 24-Aug, Vital Chemtech Ltd's stock price is rising to 53.78, up 5.0%, driven by strong performance today and favorable short-term moving averages. Despite a year-to-date decline, the stock has shown a significant one-month increase of 14.91%, indicating a potential recovery.

As of 24-Aug, Vital Chemtech Ltd's stock price is rising, currently at 53.78, reflecting an increase of 2.56 or 5.0%. This upward movement can be attributed to its performance today, where it outperformed the sector by 5.01%. Additionally, the stock is trading higher than its 5-day, 20-day, and 50-day moving averages, indicating a short-term positive trend. <BR><BR>Despite a year-to-date decline of 8.54% and a 3-year drop of 48.49%, the recent one-month performance shows a significant increase of 14.91%, which suggests a recovery phase. The stock's liquidity is also adequate for trading, which may contribute to its rising price. Overall, the combination of today's strong performance relative to the sector and favorable short-term moving averages supports the rise in Vital Chemtech Ltd's stock price.

Which are the latest news on Vital Chemtech?

Should I buy, sell or hold Vital Chemtech Ltd?

Who are in the management team of Vital Chemtech?

The management team of Vital Chemtech includes Vipul Jatashanker Bhatt (Chairman & Managing Director), Jay Vipul Bhatt and Sangeeta Vipul Bhatt (Whole-time Directors), Deepakkumar Kushalchandra Chaubisa and Hetalkumar Jayantilal Shah (Non-Executive & Independent Directors), and Puja Paras Mehta (Company Secretary).

The management team of Vital Chemtech includes the following individuals:<BR><BR>1. **Vipul Jatashanker Bhatt** - Chairman & Managing Director<BR>2. **Jay Vipul Bhatt** - Whole-time Director<BR>3. **Sangeeta Vipul Bhatt** - Whole-time Director<BR>4. **Deepakkumar Kushalchandra Chaubisa** - Non-Executive & Independent Director<BR>5. **Hetalkumar Jayantilal Shah** - Non-Executive & Independent Director<BR>6. **Puja Paras Mehta** - Company Secretary<BR><BR>If you have any more questions about the company or its operations, feel free to ask!

What does Vital Chemtech do?

Vital Chemtech Ltd, a Micro Cap company in the Chemicals & Petrochemicals industry, reported net sales of 35 Cr and a net profit of 1 Cr for March 2026. The company has a market cap of INR 141 Cr and a P/E ratio of 122.00.

Overview: <BR>Vital Chemtech Ltd operates in the Chemicals & Petrochemicals industry and is classified as a Micro Cap company.<BR><BR>History: <BR>Vital Chemtech Limited was originally incorporated in 2013 as Rudra Chemtech Private Limited. It transitioned to a Limited Liability Partnership in 2015, changing its name to Vital Chemtech Limited Liability Partnership. The most recent quarterly results reported net sales and net profit for March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 35 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 1 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 141 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 122.00 <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.61 <BR>Return on Equity: 1.04% <BR>Price to Book: 1.35 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the Vital Chemtech?

Vital Chemtech's peers include Arvee Laborat., Indian Phosphate, Jocil, Par Drugs & Che., Hindcon Chemical, Paragon Fine, Indian Emuls, Unilex Colour &C, Vadivarhe Speci., and Nilachal Carbo. Management and growth risks are generally below average for Vital Chemtech and its peers, with varying capital structures and returns among them.

Peers: The peers of Vital Chemtech are Arvee Laborat., Indian Phosphate, Jocil, Par Drugs & Che., Hindcon Chemical, Paragon Fine, Indian Emuls, Unilex Colour &C, Vadivarhe Speci., and Nilachal Carbo.<BR><BR>Quality Snapshot: Excellent management risk is observed at Paragon Fine and Indian Phosphate, while Average management risk is found at Jocil, Par Drugs & Che., Hindcon Chemical, and Indian Emuls, and the rest. Below Average management risk is noted at Arvee Laborat., Vital Chemtech, Unilex Colour &C, Vadivarhe Speci., and Nilachal Carbo. Growth is Excellent at Indian Emuls, while Average growth is seen at Indian Phosphate, Jocil, Par Drugs & Che., Hindcon Chemical, and the rest. Below Average growth is present at Arvee Laborat., Vital Chemtech, Paragon Fine, Unilex Colour &C, Vadivarhe Speci., and Nilachal Carbo. Capital Structure is Excellent at Indian Phosphate, Par Drugs & Che., and Paragon Fine, Good at Hindcon Chemical and Arvee Laborat., and Below Average at Vital Chemtech, Unilex Colour &C, Vadivarhe Speci., and Nilachal Carbo.<BR><BR>Return Snapshot: Indian Phosphate has the highest 1-year return at 21.21%, while Indian Emuls has the lowest at -71.40%, with Vital Chemtech's 1-year return being N/A. Additionally, Hindcon Chemical, Indian Emuls, Unilex Colour &C, and Nilachal Carbo all report negative six-month returns.

How big is Vital Chemtech?

As of 13th August, Vital Chemtech Ltd has a market capitalization of 141.00 Cr, with recent net sales of 96.96 Cr and a net profit of 0.68 Cr. Shareholder's funds are valued at 92.14 Cr, and total assets amount to 181.64 Cr.

As of 13th August, Vital Chemtech Ltd has a market capitalization of 141.00 Cr, which categorizes it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 96.96 Cr and a Net Profit of 0.68 Cr. This indicates a modest performance in terms of sales and a small gain in net profit over the specified periods.<BR><BR>The latest annual reporting period for the balance sheet is March 2025. During this period, Shareholder's Funds were valued at 92.14 Cr, while Total Assets amounted to 181.64 Cr.

Is Vital Chemtech overvalued or undervalued?

As of November 18, 2025, Vital Chemtech is considered very expensive and overvalued with a PE Ratio of 30.13, despite being lower than some peers, as it has underperformed significantly with a year-to-date return of -22.02% compared to the Sensex's gain of 9.58%.

As of 18 November 2025, the valuation grade for Vital Chemtech has moved from attractive to very expensive, indicating a significant shift in its market positioning. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE Ratio of 30.13, an EV to EBITDA of 19.72, and a Price to Book Value of 1.47, all of which suggest a premium valuation compared to industry norms.<BR><BR>In comparison to its peers, Vital Chemtech's PE Ratio is notably lower than that of Solar Industries at 94.24 and Gujarat Fluoroch at 57.77, but still higher than Godrej Industries, which is rated attractive with a PE of 37.03. The company's recent stock performance has been poor, with a year-to-date return of -22.02%, significantly underperforming the Sensex's gain of 9.58% during the same period, reinforcing the notion that the stock may be overvalued in the current market context.

How has been the historical performance of Vital Chemtech?

Vital Chemtech has experienced significant sales growth from 57.61 Cr in Mar'22 to 133.90 Cr in Mar'25, despite profitability challenges and fluctuating cash flows, including a loss in Mar'24. Total assets increased from 81.25 Cr to 181.64 Cr during the same period, indicating overall growth despite rising raw material costs.

Answer:<BR>The historical performance of Vital Chemtech shows significant fluctuations in key financial metrics over the past four years.<BR><BR>Breakdown:<BR>Vital Chemtech's net sales increased from 57.61 Cr in Mar'22 to 133.90 Cr in Mar'25, demonstrating strong growth, despite a dip to 98.27 Cr in Mar'24. Total operating income followed a similar trend, reaching 133.90 Cr in Mar'25 after a peak of 116.74 Cr in Mar'23. However, raw material costs surged from 38.11 Cr in Mar'22 to 107.39 Cr in Mar'25, impacting profitability. Operating profit (PBDIT) fluctuated, peaking at 14.92 Cr in Mar'23 but dropping to 13.35 Cr in Mar'25, while profit before tax saw a decline to 6.21 Cr in Mar'25 from 11.48 Cr in Mar'23. The profit after tax also reflected this volatility, with a loss of 1.30 Cr in Mar'24 turning into a profit of 4.06 Cr in Mar'25. The total assets of the company increased significantly from 81.25 Cr in Mar'22 to 181.64 Cr in Mar'25, alongside total liabilities rising from 81.25 Cr to 181.64 Cr in the same period. Cash flow from operating activities improved to 6.00 Cr in Mar'25, although the net cash inflow remained at 0.00 Cr, indicating challenges in cash management. Overall, while Vital Chemtech has shown growth in sales and assets, it has faced profitability challenges and fluctuating cash flows.

Who are the top shareholders of the Vital Chemtech?

The top shareholders of Vital Chemtech include promoter Vipul Bhatt, who holds 55.11% of the shares, with no pledged holdings. Other notable shareholders are three foreign institutional investors with 1.78% combined and Craft Emerging Market Fund Pcc- Elite Capital Fund, the highest public shareholder at 1.62%.

The top shareholders of Vital Chemtech include the promoters, with Vipul Bhatt being the largest individual shareholder, holding 55.11% of the company's shares. There are no pledged promoter holdings reported. In addition, the company has three foreign institutional investors (FIIs) holding a combined 1.78% of the shares. The highest public shareholder is Craft Emerging Market Fund Pcc- Elite Capital Fund, which holds 1.62%. Individual investors collectively own 20.82% of the shares.

What is the technical trend for Vital Chemtech?

As of May 5, 2025, Vital Chemtech's technical trend is mildly bearish, influenced by bearish moving averages and mixed signals from other indicators like the MACD and Bollinger Bands.

As of 5 May 2025, the technical trend for Vital Chemtech has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the daily moving averages remain bearish. The Bollinger Bands and KST are bearish on the weekly timeframe, and the OBV shows a mildly bearish trend. The RSI does not provide any signals on both weekly and monthly timeframes. Overall, the current technical stance is mildly bearish, driven primarily by the bearish moving averages and the mixed signals from other indicators.

When is the next results date for Vital Chemtech?

No Upcoming Board Meetings

Has Vital Chemtech declared dividend?

Vital Chemtech Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of September 13, 2024. However, total returns over various periods show significant price declines, with limited contributions from dividends.

Vital Chemtech Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 13 Sep 24<BR><BR>Dividend Yield: 0.77%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -15.14%, the dividend return was 0%, resulting in a total return of -15.14%.<BR><BR>Over the past year, the price return was -15.53%, with a dividend return of 0.67%, leading to a total return of -14.86%.<BR><BR>In the 2-year period, the price return was -43.94%, the dividend return was 0.93%, resulting in a total return of -43.01%.<BR><BR>For the 3-year period, there was no price return, no dividend return, and the total return was 0.0%.<BR><BR>In the 4-year period, the price return was 0%, the dividend return was 0%, and the total return was 0.0%.<BR><BR>Lastly, over the 5-year period, the price return was 0%, the dividend return was 0%, leading to a total return of 0.0%.<BR><BR>Overall, while Vital Chemtech has declared a dividend, the total returns over various periods indicate significant declines in price, with limited dividend contributions in the longer term.